ReviewObesity pillars2026

Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it.

Sonya T Gelfand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.